Golam Mohi

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “U2af1 is required for survival and function of hematopoietic stem/progenitor cells”.

U2af1 is required for survival and function of hematopoietic stem/progenitor cells

Leukemia(2021)10.1038/s41375-020-01116-x

N/A

0DataRank · unranked

41 citations

Yue Yang, Bao T. Le, Yifan Zhang, Omar Abdel-Wahab, Chongzhi Zang +2 more

CDK6 Is a Therapeutic Target in Myelofibrosis

Cancer Research(2021)10.1158/0008-5472.can-21-0590

N/A

0DataRank · unranked

21 citations

Dipmoy Nath, Yue Yang, Bao T. Le, Golam Mohi, Avik Dutta

Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm

Nature Communications(2022)10.1038/s41467-022-32928-3

N/A

0DataRank · unranked

52 citations

Yue Yang, Bao T. Le, Avik Dutta, Julia Posyniak, Patrick Faughnan +4 more

SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm

Blood Cancer Journal(2023)10.1038/s41408-023-00947-y

N/A

0DataRank · unranked

8 citations

Salar Abbas, Mohammad Sayem, Avik Dutta, Golam Mohi, Yue Yang

Data from CDK6 Is a Therapeutic Target in Myelofibrosis

(2023)10.1158/0008-5472.c.6513271.v1

N/A

0DataRank · unranked

0 citations

Dipmoy Nath, Yue Yang, Bao T. Le, Golam Mohi, Avik Dutta

A blockade of leukotriene-mediated Alox5 function provides a new strategy for the treatment of JAK2V617F-induced polycythemia vera

Haematologica(2025)10.3324/haematol.2024.287186

N/A

0DataRank · unranked

0 citations

Ngoc DeSouza, Noah Littman, Qiang Qiu, Kathy Nguyen, Yehua Yu +3 more